PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.434
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search